As of 2025-09-16, the Relative Valuation of Madrigal Pharmaceuticals Inc (MDGL) is (264.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 425.60 USD, the upside of Madrigal Pharmaceuticals Inc based on Relative Valuation is -162.1%.
The range of the Relative Valuation is (238.01) - (298.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 26.2x | 22.3x |
| Forward P/E multiples | 17.1x - 23.6x | 19.5x |
| Fair Price | (238.01) - (298.72) | (264.32) |
| Upside | -155.9% - -170.2% | -162.1% |
| Date | P/E |
| 2025-09-12 | -34.18 |
| 2025-09-11 | -34.75 |
| 2025-09-10 | -34.01 |
| 2025-09-09 | -35.48 |
| 2025-09-08 | -35.88 |
| 2025-09-05 | -34.23 |
| 2025-09-04 | -34.10 |
| 2025-09-03 | -34.42 |
| 2025-09-02 | -34.48 |
| 2025-08-29 | -34.62 |
| 2025-08-28 | -34.57 |
| 2025-08-27 | -33.61 |
| 2025-08-26 | -33.59 |
| 2025-08-25 | -32.60 |
| 2025-08-22 | -32.79 |
| 2025-08-21 | -32.19 |
| 2025-08-20 | -30.97 |
| 2025-08-19 | -30.01 |
| 2025-08-18 | -30.95 |
| 2025-08-15 | -29.24 |
| 2025-08-14 | -29.36 |
| 2025-08-13 | -29.53 |
| 2025-08-12 | -28.39 |
| 2025-08-11 | -27.64 |
| 2025-08-08 | -27.34 |
| 2025-08-07 | -27.07 |
| 2025-08-06 | -26.73 |
| 2025-08-05 | -26.80 |
| 2025-08-04 | -24.68 |
| 2025-08-01 | -23.89 |
| 2025-07-31 | -23.92 |
| 2025-07-30 | -22.92 |
| 2025-07-29 | -23.28 |
| 2025-07-28 | -23.26 |
| 2025-07-25 | -23.59 |
| 2025-07-24 | -23.66 |
| 2025-07-23 | -24.26 |
| 2025-07-22 | -24.78 |
| 2025-07-21 | -26.17 |
| 2025-07-18 | -26.42 |
| 2025-07-17 | -27.57 |
| 2025-07-16 | -27.28 |
| 2025-07-15 | -24.60 |
| 2025-07-14 | -25.29 |
| 2025-07-11 | -24.94 |
| 2025-07-10 | -24.88 |
| 2025-07-09 | -24.40 |
| 2025-07-08 | -22.73 |
| 2025-07-07 | -22.86 |
| 2025-07-03 | -23.63 |